TD SYNNEX Corporation filings document the operating results, governance, capital structure and material agreements of a New York Stock Exchange-listed IT distributor and solutions aggregator. Recent 8-K reports include quarterly financial results, dividend announcements, amendments to the company’s charter and bylaws, executive officer changes, and financing arrangements.
The company’s SEC record also includes proxy materials covering board matters, executive compensation and stockholder voting items. Other filings describe its accounts receivable securitization program, senior notes issued under shelf registration documents, underwriting agreements, indenture covenants, common stock registration details and related risk, governance and capital-allocation disclosures.
TD SYNNEX director and Hyve Solutions chair Dennis Polk reported pre-planned sales of company stock held in a family trust. On behalf of the Polk Family Trust, for which he serves as trustee, the trust sold a total of 2,500 shares of TD SYNNEX common stock in open-market transactions on May 15, 2026.
The shares were sold in three blocks: 600 shares at a weighted average price of $231.26, 900 shares at $230.49, and 1,000 shares at $229.74, each representing multiple trades within stated price ranges. Following these sales, the trust holds 80,647 shares indirectly, and Polk also holds 22,439 shares directly. The transactions were executed under a Rule 10b5-1 trading plan adopted on January 16, 2026.
TD SYNNEX Corporation updated the employment terms for Dennis Polk as Chair, Hyve Solutions Holdings, effective December 1, 2025. He will continue reporting solely to the CEO and remain on the Board of Directors.
Under the new offer letter, Mr. Polk will receive an annual base salary of $840,000 and be eligible for an annual incentive bonus targeted at 100% of his base salary, based on performance metrics set by the Board’s Compensation Committee. He is also slated to receive equity awards in TD SYNNEX common stock with a fair market value of approximately $1,500,000, allocated 60% to time-based restricted stock and 40% to performance-based restricted stock units, granted alongside other executives’ annual awards.
The offer letter includes severance protections, providing certain payments if Mr. Polk is terminated without “cause” or resigns for “good reason,” including similar provisions tied to a change of control of the company.
TD SYNNEX CORP director Richard T. Hume reported open-market sales of a total of 5,000 shares of TD SYNNEX common stock on May 5, 2026. The shares were sold in multiple blocks at prices between approximately $230 and $235 per share.
According to the filing, these transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted by Hume on February 2, 2026. All transactions involved non-derivative common stock, and the filing does not show any option exercises or derivative activity.
SNX reports a Form 144 notice for the proposed sale of 20,000 shares of Common Stock previously acquired as Restricted Stock Units on 06/30/2020. The filing shows 5,000 shares were sold by Richard T. Hume on 03/02/2026, and the form lists an exchange and filing reference date of 05/05/2026.
TD SYNNEX director Merline Saintil sold Common Stock in an open-market transaction. On May 4, 2026, she sold 4,368 shares of TD SYNNEX Common Stock at a weighted average price of $229.26 per share, with individual sale prices ranging from $229.00 to $229.79. Following this sale, she directly held 3,649 shares of Common Stock.
Morgan Stanley Smith Barney LLC submitted a Form 144 notice listing proposed sales of restricted common stock that vested under a registered plan on multiple dates. The filing lists individual vesting events and share counts (examples: 494 shares on 11/30/2023, 274 shares on 08/31/2024), all tied to services rendered.
TD SYNNEX President, North America Reyna Thompson reported open-market sales of 2,196 shares of common stock. The transactions occurred on April 29, 2026 in three tranches at weighted average prices of $222.39, $223.52, and $224.27 per share.
The sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on January 28, 2026, indicating they were scheduled in advance rather than timed opportunistically.
TD SYNNEX Corp reports that Vanguard Portfolio Management beneficially owned 4,182,115 shares of Common Stock (CUSIP 87162W100), representing 5.18% of the class as of 03/31/2026. The filing states Vanguard Portfolio Management exercises sole dispositive power over those shares and discloses sole voting power for 23,419 shares.
TD SYNNEX CORP director and officer Dennis Polk reported an open-market sale of 2,500 shares of Common Stock on April 17, 2026, at an average price of $210.70 per share. The shares were sold by the Polk Family Trust, where Polk is a trustee, under a pre-arranged Rule 10b5-1 trading plan adopted on January 16, 2026. Following this transaction, the filing shows 81,647 shares held indirectly by trust and 22,439 shares held directly.